Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

SmithKline Beecham's penciclovir available in U.K. market

June 7, 1996

Toyama reveals antiherpes compounds

June 7, 1996

A7-183: Effective topical therapy of recurrent herpes labialis and genitalis

June 7, 1996

Xoma granted U.S. patent for use of BPI

June 7, 1996

Kyowoa Hakko's RP-1551-2: a novel antimicrobial agent

June 7, 1996

Glaxo Wellcome and Otsuka sign grepafloxacin licensing agreement

June 7, 1996

Antiherpes prodrug shows greater activity than aciclovir

May 31, 1996

FDA approves piperacillin sodium/tazobactam sodium for new indication

May 31, 1996

Bayer announces formulation of antibacterial agents

May 31, 1996

Clinical data from Lidakol phase III studies

May 24, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...